PMC:7652766 / 32276-32568 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T75","span":{"begin":82,"end":94},"obj":"Phenotype"},{"id":"T76","span":{"begin":128,"end":140},"obj":"Phenotype"},{"id":"T77","span":{"begin":142,"end":145},"obj":"Phenotype"}],"attributes":[{"id":"A75","pred":"hp_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/HP_0003256"},{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0003256"},{"id":"A77","pred":"hp_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":"However, COVID-19 has some distinct features that may establish a new category of coagulopathy, denominated COVID-19 associated coagulopathy (CAC), whose main markers are higher D-dimer concentration and fibrinogen levels, a relatively lower platelet count, and longer prothrombin time (129)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T162","span":{"begin":0,"end":292},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, COVID-19 has some distinct features that may establish a new category of coagulopathy, denominated COVID-19 associated coagulopathy (CAC), whose main markers are higher D-dimer concentration and fibrinogen levels, a relatively lower platelet count, and longer prothrombin time (129)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1288","span":{"begin":204,"end":214},"obj":"Gene"},{"id":"1293","span":{"begin":223,"end":224},"obj":"Gene"},{"id":"1294","span":{"begin":64,"end":65},"obj":"Gene"},{"id":"1304","span":{"begin":9,"end":17},"obj":"Disease"},{"id":"1305","span":{"begin":82,"end":94},"obj":"Disease"},{"id":"1306","span":{"begin":108,"end":116},"obj":"Disease"},{"id":"1307","span":{"begin":128,"end":140},"obj":"Disease"}],"attributes":[{"id":"A1288","pred":"tao:has_database_id","subj":"1288","obj":"Gene:2244"},{"id":"A1293","pred":"tao:has_database_id","subj":"1293","obj":"Gene:351"},{"id":"A1294","pred":"tao:has_database_id","subj":"1294","obj":"Gene:351"},{"id":"A1304","pred":"tao:has_database_id","subj":"1304","obj":"MESH:C000657245"},{"id":"A1305","pred":"tao:has_database_id","subj":"1305","obj":"MESH:D001778"},{"id":"A1306","pred":"tao:has_database_id","subj":"1306","obj":"MESH:C000657245"},{"id":"A1307","pred":"tao:has_database_id","subj":"1307","obj":"MESH:D001778"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, COVID-19 has some distinct features that may establish a new category of coagulopathy, denominated COVID-19 associated coagulopathy (CAC), whose main markers are higher D-dimer concentration and fibrinogen levels, a relatively lower platelet count, and longer prothrombin time (129)."}